Inhibitors | Comment | Organism | Structure |
---|---|---|---|
sorafenib | - |
Homo sapiens | |
sorafenib N-oxide | both sorafenib and sorafenib N-oxide interacts with active site residues in CYP2C8, but four additional major hydrogen and halogen bonding interactions are identified between sorafenib N-oxide and amino acids in the B-B' loop region and helixes F' and I of the the catalytic region | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
microsome | - |
Homo sapiens | - |
- |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P10632 | isoform CYP2C8 | - |
Homo sapiens | P11712 | isoform CYP2C9 | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
losartan + [reduced NADPH-hemoprotein reductase] + O2 | - |
Homo sapiens | ? + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
paclitaxel + [reduced NADPH-hemoprotein reductase] + O2 | - |
Homo sapiens | 6alpha-hydroxypaclitaxel + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? |
Synonyms | Comment | Organism |
---|---|---|
CYP2C8 | - |
Homo sapiens |
CYP2C9 | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.014 | - |
pH 7.4, 37°C | Homo sapiens | sorafenib N-oxide | |
0.036 | - |
pH 7.4, 37°C | Homo sapiens | sorafenib | |
0.04 | - |
pH 7.4, 37°C | Homo sapiens | sorafenib N-oxide | |
0.051 | - |
pH 7.4, 37°C | Homo sapiens | sorafenib |